The greatest constraint many innovations face is funding the start up phase. This is the point where your evidence generation should be completed (or at least well underway), and you have planned your market entry but now need to scale up into an actual company.

Some of the costs to consider will be:

  • Staff
  • Places e.g. an office location
  • Manufacturing
  • IP costs e.g. licensing (especially if your IP is owned by Imperial)
  • Marketing
  • Fees for regulatory requirements e.g. FDA submissions, MHRA submissions etc.
  • Any further evidence generation and validation studies

You will likely need to acquire funding from multiple sources, but as a start, consider:

 

Resource Download / Contact Us

You can download a copy of this section here: Idea to Adoption Part 8 (PDF)

If you would like to contact us, or if there is a resource you would like to see, reach out to us using this form!

Subscribe to the MedTechONE mailing list

Subscribe here

Follow us on LinkedIn

Follow us on LinkedIn